Many patients benefit from consulting with healthcare providers about tapering strategies or transitioning to lower maintenance doses rather than complete discontinuation
Methionine offers the benefits of requiring a shorter treatment duration (12 hours vs
Still, they can cause side effects such as nausea, diarrhea, constipation, or vomiting, especially at higher doses
The first biosimilar semaglutide products are not expected before the early 2030s at the earliest, and even then, biosimilar pricing typically settles at only 20-40% below the reference product due to the ongoing costs of biologic manufacturing
More recently, tirzepatide, which targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors, has received approval for treating type 2 diabetes and/or obesity